Ultromics

The AI tool is FDA 510(k) cleared and holds Breakthrough Device Designation.

“FDA 510(k) cleared.”Ultromics, own website

Ultromics integrates seamlessly with existing ultrasound and PACS environments without workflow changes.

“Ultromics AI analyzes standard echo studies after acquisition and returns results into existing clinical systems, integrating with ultrasound and PACS environments without changing how studies are scanned, read, or reported.”Ultromics, own website

#7 in AI clinical decision support tools for hospitals · Lister Score 78.0

Integrates seamlessly with existing ultrasound and PACS environments without workflow changes.

How the score is made up: fit to this ranking's criteria 40; evidence on its own site 20; how complete its published information is 14; buying information on its own site 4.

“Ultromics provides FDA-cleared, clinically validated AI to help identify patients with HFpEF and cardiac amyloidosis by analyzing routine echocardiograms within existing workflows, supporting the identification of two severely undiagnosed conditions.”Ultromics, own website

“U.S. hospitals are using Ultromics technology to support heart failure assessment.”Ultromics, own website